How many email patterns does Genelux use?

Genelux uses 8 known email patterns.

What domain does Genelux use for work emails?

Genelux uses genelux.com for work email addresses.

Most Common Email Formats at Genelux

Genelux's most common email format is First.Last@genelux.com (ex. John.Doe@genelux.com), used for 59% of genelux.com addresses. Genelux uses 4 email patterns.

@genelux.com

4 patterns

Format	Example	Share of genelux.com
First.Last@genelux.comMost common	John.Doe@genelux.com	59%
FirstLast@genelux.com	JohnDoe@genelux.com	24%
First@genelux.com	John@genelux.com	10%
FLast@genelux.com	JDoe@genelux.com	7%

Frequently Asked Questions

What does Genelux do?

Genelux was founded in 2001 and operates in the Biotechnology Research industry, alongside similar companies like Roche, sanofi and Johnson & Johnson. You can visit genelux.com. Explore Genelux's company overview page for more information.

What is Genelux's email address format?

Genelux's email format typically follows the pattern of First.Last@genelux.com; this email format is used 59% of the time. Other contacts within LeadIQ's database had email formats such as FirstLast@genelux.com and First@genelux.com. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does Genelux have currently?

Genelux has approximately 34 employees as of October 2026. Key team members to contact include Head Of Regulatory: R. S., Vice-President: J. S. and Clinical Trial Operations Associate: A. P. For more team information and contact data, explore Genelux's employee directory with LeadIQ.

Genelux Email Format

Q: What is Genelux's email address format?

Genelux's email format typically follows the pattern of ${fn}.${ln}. Other email formats include ${fn}${ln} and ${fn}.

Biotechnology ResearchCalifornia, United States11-50 Employees

Genelux is a late clinical-stage biotechnology company based in Westlake Village, California, focused on developing immuno-oncology therapies for difficult-to-treat solid tumors. Its lead candidate, Olvi-Vec, is being advanced in registrational Phase 3 testing for platinum-resistant/refractory ovarian cancer, with additional development in non-small cell lung cancer, recurrent small cell lung cancer, and recurrent ovarian cancer. The company aims to deliver personalized anti-tumor immune responses by leveraging its Choice Discovery Platform, which has generated hundreds of vaccinia virus variants to stimulate tumor neo-antigen presentation. Genelux serves oncology researchers and patients facing aggressive solid tumors, pursuing a pipeline of next-generation oncolytic immunotherapies. Recent updates indicate ongoing Phase 3 trial progression and updates on systemic lung cancer programs, reflecting continued clinical development activity.

Most Common Email Formats at Genelux

@genelux.com

Need a specific person's email?

Frequently Asked Questions

What does Genelux do?

What is Genelux's email address format?

How many employees does Genelux have currently?

Genelux Email Format

Ready to create more pipeline?

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Most Common Email Formats at Genelux

@genelux.com

Need a specific person's email?

Frequently Asked Questions

What does Genelux do?

What is Genelux's email address format?

How many employees does Genelux have currently?

Genelux Email Format

Ready to create more pipeline?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Everything for prospecting,
in one platform.